APA (7th ed.) Citation

TANIWAKI, M., STEFANINI, G. G., SILBER, S., RICHARDT, G., VRANCKX, P., SERRUYS, P. W., . . . WINDECKER, S. (2014). 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents: A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). Journal of the American College of Cardiology, 63(16), 1617-1625. https://doi.org/10.1016/j.jacc.2013.12.036

Chicago Style (17th ed.) Citation

TANIWAKI, Masanori, Giulio G. STEFANINI, Sigmund SILBER, Gert RICHARDT, Pascal VRANCKX, Patrick W. SERRUYS, Pawel E. BUSZMAN, Henning KELBAEK, and Stephan WINDECKER. "4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents: A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)." Journal of the American College of Cardiology 63, no. 16 (2014): 1617-1625. https://doi.org/10.1016/j.jacc.2013.12.036.

MLA (9th ed.) Citation

TANIWAKI, Masanori, et al. "4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents: A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)." Journal of the American College of Cardiology, vol. 63, no. 16, 2014, pp. 1617-1625, https://doi.org/10.1016/j.jacc.2013.12.036.